Hideki Koizumi

Hideki Koizumi

Auto-generated profile, based on publicly available information

Hideki Koizumi

Department of Ophthalmology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Ophthalmology Retina
Verified
Journal Article
Open access
NINaoya Imanaga
Naoya Imanaga
NTNobuhiro Terao
Nobuhiro Terao
SNSakari Nakamine
Sakari Nakamine
TTTamaki Tamashiro
Tamaki Tamashiro
SWSorako Wakugawa
Sorako Wakugawa
HKHideki Koizumi
Hideki Koizumi
To evaluate scleral thickness in central serous chorioretinopathy (CSC) using anterior-segment optical coherence tomography (AS-OCT). Retrospective, comparative study. Forty-seven eyes of 40 patients with CSC and 53 eyes of 47 age- and gender-matched normal control subjects. Spherical equivalent, axial length, subfoveal choroidal thickness, and scleral thickness were compared between the CSC and control groups. Scleral thickness was measured by AS-OCT 6 mm posterior to the scleral spur in four directions. Scleral thickness in CSC eyes. There were no differences between the two groups in age, gender, spherical equivalent, or axial length. Subfoveal choroidal thickness was significantly greater in CSC eyes than in normal controls (424.0 ± 101.4 vs. 324.3 ± 91.8 μm, P < 0.001). Scleral thickness was significantly greater in CSC eyes than in normal controls at the superior (429.4 ± 50.3 vs. 395.2 ± 55.4 μm, P = 0.005), temporal (447.7 ± 45.7 vs. 396.5 ± 64.1 μm, P < 0.001), inferior (455.7 ± 81.2 vs. 437.8 ± 46.9 μm, P = 0.022), and nasal (454.9 ± 44.7 vs. 416.6 ± 51.2 μm, P = 0.001) points. Scleral thickness measured by AS-OCT was significantly greater in CSC eyes than in normal control eyes, although there were no differences in spherical equivalent and axial length. Thick sclera may have a role in the pathogenesis of CSC.

1 March 2016 in Ophthalmology
Verified
Journal Article
Closed access
HKHideki Koizumi
Hideki Koizumi
MKMariko Kano
Mariko Kano
AYAkiko Yamamoto
Akiko Yamamoto
MSMasaaki Saito
Masaaki Saito
IMIchiro Maruko
Ichiro Maruko
TITomohiro Iida
Tomohiro Iida

3 August 2024 in Eye
Verified
Journal Article
Open access
PDF file
CCChui Ming Gemmy Cheung
Chui Ming Gemmy Cheung
KDKunal K. Dansingani
Kunal K. Dansingani
HKHideki Koizumi
Hideki Koizumi
TLTimothy Y. Y. Lai
Timothy Y. Y. Lai
SSSobha Sivaprasad
Sobha Sivaprasad
KFK. Bailey Freund
K. Bailey Freund
The pachychoroid disease spectrum is a phenotype characterized by alterations in choroidal vasculature which result in outer retinal and choriocapillaris damage and visual loss. The presence of pachyvessels is one of the key features of the pachychoroid phenotype. Recent imaging studies suggest that pachyvessels may form because of choroidal venous congestion in one or more quadrants. The formation of intervortex anastomosis may function as a compensatory mechanism to dissipate the increased venous pressure, while outflow obstruction has been hypothesized to occur at the site of the vortex vein exiting the sclera. This review aims to summarize recent imaging findings and discuss evolution in the understanding of pathogenesis of the pachychoroid disease spectrum. We have summarized notable treatment trials in central serous chorioretinopathy and polypoidal choroidal vasculopathy and included an update of the current diagnostic and management strategies of the entities that are part of the pachychoroid disease spectrum.

1 April 2015 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
HKHideki Koizumi
Hideki Koizumi
MKMariko Kano
Mariko Kano
AYAkiko Yamamoto
Akiko Yamamoto
MSMasaaki Saito
Masaaki Saito
IMIchiro Maruko
Ichiro Maruko
TITomohiro Iida
Tomohiro Iida

12 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NTNobuhiro Terao
Nobuhiro Terao
HKHideki Koizumi
Hideki Koizumi
KKKentaro Kojima
Kentaro Kojima
TYTetsuya Yamagishi
Tetsuya Yamagishi
YYYuji Yamamoto
Yuji Yamamoto
JHJunji Hamuro
Junji Hamuro
This study investigated the pathophysiological features of pachychoroid neovasculopathy (PNV) and neovascular age-related macular degeneration (nAMD) by analysing and comparing cytokine profiles in aqueous humour (AH) collected from 18 PNV, 18 nAMD and 11 control patients. Responses to intravitreal injection of aflibercept were also analysed in the PNV and nAMD groups. In the PNV group, vascular endothelial growth factor (VEGF)-A was significantly lower than in the nAMD group (p = 0.03) but was almost identical to that in the control group (p = 0.86). The nAMD group showed positive correlations between interleukin (IL)-6 and IL-8 (r = 0.78, p < 0.001), IL-6 and monocyte chemoattractant protein (MCP)-1 (r = 0.68, p = 0.002) and IL-8 and MCP-1 (r = 0.68, p = 0.002). In the nAMD group, eyes with dry maculae one month after the first aflibercept injection showed significantly lower VEGF-A and placental growth factor (PlGF) at baseline than those with wet maculae (p = 0.02 for both). However, there was no significant difference between dry and wet maculae in the PNV group. The results suggest that angiogenic factors and proinflammatory cytokines may play the distinct roles in the pathogenesis of PNV and nAMD.

8 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KYKenji Yamashiro
Kenji Yamashiro
YYYasuo Yanagi
Yasuo Yanagi
HKHideki Koizumi
Hideki Koizumi
HMHidetaka Matsumoto
Hidetaka Matsumoto
CCChui Ming Gemmy Cheung
Chui Ming Gemmy Cheung
ATAkitaka Tujikawa
Akitaka Tujikawa
Previous clinical studies have suggested that pachychoroid can induce macular neovascularization (MNV) to develop pachychoroid neovasculopathy (PNV) and that PNV can progress to polypoidal choroidal vasculopathy (PCV). Recent studies based on the pachychoroid concept are now gradually revealing the true nature of, at least some part of, PCV. However, previous studies on PNV and/or PCV have used different frameworks for the classification of PNV, PCV, and neovascular age-related macular degeneration (nAMD). These have hampered the rapid overhaul of the understanding of PCV. Some investigators have assumed that all PCV is pachychoroid-driven whereas other investigators have classified PCV into “pachychoroid PCV” and “non-pachychoroid PCV”. Furthermore, since there is no consensus as to whether PNV includes PCV, some studies have included PCV with PNV, while other studies have excluded PCV from PNV. To address these gaps, we summarize previous studies on PCV and pachychoroid. Even before the proposal of the pachychoroid concept, previous studies had suggested that PCV could be divided into two subtypes, of which one was characterized by pachychoroid features. Previous studies had also provided keys to understand relationship between PCV and PNV. We here recommend a refined conceptual framework for future studies on PNV, PCV, and nAMD. Considering the current inconsistent understanding of PCV, we should be cautious about using the term PCV until we understand the true nature of PCV.